Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QUEST trial of Qiliqiangxin in chronic heart failure
ChiCTR1900021929Phase 4Not yet recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of qiliqiangxin in chronic heart failure (CHF) (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Composite of cardiovascular death and rehospitalization due to worsening heart failure. Planned start Aug 2018; status: not yet recruiting.
02
Drugs
qiliqiangxin
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on ChiCTR1900021929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021929.